Lipocine
LPCN
LPCN
46 hedge funds and large institutions have $9.54M invested in Lipocine in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
91% less capital invested
Capital invested by funds: $102M → $9.54M (-$92.4M)
Holders
46
Holding in Top 10
–
Calls
$928K
Puts
$36K
Top Buyers
| 1 | +$199K | |
| 2 | +$160K | |
| 3 | +$134K | |
| 4 |
Two Sigma Investments
New York
|
+$78.9K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$68K |
Top Sellers
| 1 | -$901K | |
| 2 | -$171K | |
| 3 | -$97.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$86K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$54K |